487
Views
26
CrossRef citations to date
0
Altmetric
Review

Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease – a patent review (2016–present)

, , , ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 399-420 | Received 21 Sep 2020, Accepted 07 Jan 2021, Published online: 14 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Roque Spinelli, Álvaro Rietmann, Ivan Sanchis & Álvaro Sebastián Siano. (2022) Natural multi-target modulators of pathological pathways in Alzheimer's disease isolated from the Rhinella arenarum skin. Natural Product Research 36:12, pages 3193-3197.
Read now

Articles from other publishers (25)

Yan Bai, Duo Ren, Xinlei Xue, Weixian Gao, Jiangchun Hu & Huaqi Pan. (2024) Structurally diverse brefeldin A derivatives as potent and selective acetylcholinesterase inhibitors from an endophytic fungus Penicillium brefeldianum F4a. Arabian Journal of Chemistry 17:1, pages 105388.
Crossref
Guoxing Wang, Jiyu Du, Jie Ma, Peipei Liu, Siqi Xing, Jucheng Xia, Shuanghong Dong & Zeng Li. (2023) Discovery of Novel Tryptanthrin Derivatives with Benzenesulfonamide Substituents as Multi-Target-Directed Ligands for the Treatment of Alzheimer’s Disease. Pharmaceuticals 16:10, pages 1468.
Crossref
Paulo Cézar Prado, Josélia Alencar Lima, Lidilhone Hamerski & Magdalena Nascimento Rennó. (2023) Natural Products with BACE1 and GSK3β Inhibitory Activity. Mini-Reviews in Medicinal Chemistry 23:7, pages 881-895.
Crossref
Nisekhoto Nisa, Borgohain Rasmita, Chettri Arati, Chetia Uditraj, Rajkonwar Siddhartha, Roy Dinata, Baishya Bhanushree, Rema Momin Bidanchi, Bose Manikandan, Saeed Ahmed Laskar, Giri Abinash, Buragohain Pori, Vikas Kumar Roy & Guruswami Gurusubramanian. (2023) Repurposing of phyto-ligand molecules from the honey bee products for Alzheimer’s disease as novel inhibitors of BACE-1: small molecule bioinformatics strategies as amyloid-based therapy. Environmental Science and Pollution Research 30:17, pages 51143-51169.
Crossref
Mohammad Hosein Eshaghi Ghalibaf, Arezoo Rajabian, Mohsen Parviz, Mahsan Akbarian, Sabiheh Amirahmadi, Farzaneh Vafaee & Mahmoud Hosseini. (2023) Minocycline alleviated scopolamine-induced amnesia by regulating antioxidant and cholinergic function. Heliyon 9:2, pages e13452.
Crossref
Jun Guo, Xiuqing Huang, Lin Dou, Mingjing Yan, Tao Shen, Weiqing Tang & Jian Li. (2022) Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduction and Targeted Therapy 7:1.
Crossref
Md. Yousof Ali, Sumera Zaib, Susoma Jannat & Imtiaz Khan. (2022) Discovery of potent and selective dual cholinesterases and β-secretase inhibitors in pomegranate as a treatment for Alzheimer’s disease. Bioorganic Chemistry 129, pages 106137.
Crossref
Roque Spinelli, Ma. Verónica Humpola, Ivan Sanchís, Emilse de los Angeles Méndez & Alvaro Siano. (2022) Biological Characterization of Natural Peptide BcI-1003 from Boana cordobae (anura): Role in Alzheimer’s Disease and Microbial Infections. International Journal of Peptide Research and Therapeutics 29:1.
Crossref
Sarra Chortani, Amel Hajlaoui, Salma Jlizi, Abdel Halim Harrath, Hichem Ben Jannet & Anis Romdhane. (2022) Access to new phosphonate- and imidazolidine-benzopyrimidinone derivatives as antityrosinase and anti-acetylcholinesterase agents: Design, synthesis and molecular docking. Journal of Molecular Structure 1268, pages 133693.
Crossref
Noa Stern, Alexandra Gacs, Enikő Tátrai, Beáta Flachner, István Hajdú, Krisztina Dobi, István Bágyi, György Dormán, Zsolt Lőrincz, Sándor Cseh, Attila Kígyós, József Tóvári & Amiram Goldblum. (2022) Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo. International Journal of Molecular Sciences 23:21, pages 13098.
Crossref
R. Cuciniello, D. Luongo, A. Ferramosca, P. Lunetti, V. Rotondi-Aufiero, S. Crispi, V. Zara, F. Maurano, S. Filosa & P. Bergamo. (2022) Conjugated linoleic acid downregulates Alzheimer's hallmarks in aluminum mouse model through an Nrf2-mediated adaptive response and increases brain glucose transporter levels. Free Radical Biology and Medicine 191, pages 48-58.
Crossref
Samar O. El-Ganainy, Omar A. Soliman, Aya A. Ghazy, Maram Allam, Aya I. Elbahnasi, Amira M. Mansour & Mennatallah A. Gowayed. (2022) Intranasal Oxytocin Attenuates Cognitive Impairment, β-Amyloid Burden and Tau Deposition in Female Rats with Alzheimer’s Disease: Interplay of ERK1/2/GSK3β/Caspase-3. Neurochemical Research 47:8, pages 2345-2356.
Crossref
Karanvir Singh, Rohit Bhatia, Bhupinder Kumar, Gurpreet Singh & Vikramdeep Monga. (2022) Design Strategies, Chemistry and Therapeutic Insights of Multi-target Directed Ligands as Antidepressant Agents. Current Neuropharmacology 20:7, pages 1329-1358.
Crossref
Andreea L. Turcu, Júlia Companys-Alemany, Matthew B. Phillips, Dhilon S. Patel, Christian Griñán-Ferré, M. Isabel Loza, José M. Brea, Belén Pérez, David Soto, Francesc X. Sureda, Maria G. Kurnikova, Jon W. Johnson, Mercè Pallàs & Santiago Vázquez. (2022) Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease. European Journal of Medicinal Chemistry 236, pages 114354.
Crossref
Martina Bortolami, Fabiana Pandolfi, Valeria Tudino, Antonella Messore, Valentina Noemi Madia, Daniela De Vita, Roberto Di Santo, Roberta Costi, Isabella Romeo, Stefano Alcaro, Marisa Colone, Annarita Stringaro, Alba Espargaró, Raimon Sabatè & Luigi Scipione. (2022) Design, Synthesis, and In Vitro, In Silico and In Cellulo Evaluation of New Pyrimidine and Pyridine Amide and Carbamate Derivatives as Multi-Functional Cholinesterase Inhibitors. Pharmaceuticals 15:6, pages 673.
Crossref
Adnan Ahmad & Krishan Pal. (2022) Therapeutic Efficacy of Natural Phytochemicals as Acetylcholinesterase Inhibitors Against Alzheimer’s Disease. Journal of Ecophysiology and Occupational Health 22:1, pages 39.
Crossref
Reşit Çakmak, Eyüp Başaran & Murat Şentürk. (2022) Synthesis, characterization, and biological evaluation of some novel Schiff bases as potential metabolic enzyme inhibitors. Archiv der Pharmazie 355:4, pages 2100430.
Crossref
Yongmei Zhao, Yeshu Mu, Wen Luo & Zhiyong Tian. (2022) Synthesis of Naphthalimide Derivatives as Cholinesterase Inhibitors with Aggregation Induced Emission Properties. Chinese Journal of Organic Chemistry 42:3, pages 819.
Crossref
Niels Heise, Sander Friedrich, Veronika Temml, Daniela Schuster, Bianka Siewert & René Csuk. (2022) N-methylated diazabicyclo[3.2.2]nonane substituted triterpenoic acids are excellent, hyperbolic and selective inhibitors for butyrylcholinesterase. European Journal of Medicinal Chemistry 227, pages 113947.
Crossref
Caterina Pont, Tiziana Ginex, Christian Griñán-Ferré, Matthias Scheiner, Alexia Mattellone, Noemí Martínez, Elsa M. Arce, Yolanda Soriano-Fernández, Marina Naldi, Angela De Simone, Marta Barenys, Jesús Gómez-Catalán, Belén Pérez, Raimon Sabate, Vincenza Andrisano, María Isabel Loza, José Brea, Manuela Bartolini, Maria Laura Bolognesi, Michael Decker, Mercè Pallàs, F. Javier Luque & Diego Muñoz-Torrero. (2021) From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects. European Journal of Medicinal Chemistry 225, pages 113779.
Crossref
Belgin Sever, Cüneyt Türkeş, Mehlika D. Altıntop, Yeliz Demir, Gülşen Akalın Çiftçi & Şükrü Beydemir. (2021) Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds. Archiv der Pharmazie 354:12, pages 2100294.
Crossref
Martina Bortolami, Fabiana Pandolfi, Valeria Tudino, Antonella Messore, Valentina Noemi Madia, Daniela De Vita, Roberto Di Santo, Roberta Costi, Isabella Romeo, Stefano Alcaro, Marisa Colone, Annarita Stringaro, Alba Espargaró, Raimon Sabatè & Luigi Scipione. (2021) New Pyrimidine and Pyridine Derivatives as Multitarget Cholinesterase Inhibitors: Design, Synthesis, and In Vitro and In Cellulo Evaluation . ACS Chemical Neuroscience 12:21, pages 4090-4112.
Crossref
Elisa Uliassi, Andressa Souza de Oliveira, Luciana de Camargo Nascente, Luiz Antonio Soares Romeiro & Maria Laura Bolognesi. (2021) Cashew Nut Shell Liquid (CNSL) as a Source of Drugs for Alzheimer’s Disease. Molecules 26:18, pages 5441.
Crossref
Majid Balaei-Kahnamoei, Mina Saeedi, Arezoo Rastegari, Mohammad Reza Shams Ardekani, Tahmineh Akbarzadeh & Mahnaz Khanavi. (2021) Phytochemical Analysis and Evaluation of Biological Activity of Lawsonia inermis Seeds Related to Alzheimer’s Disease. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-10.
Crossref
Shikha Lohan, Teenu Sharma, Sumant Saini, Rajan Swami, Dinesh Dhull, Sarwar Beg, Kaisar Raza, Anil Kumar & Bhupinder Singh. (2021) QbD-steered development of mixed nanomicelles of galantamine: Demonstration of enhanced brain uptake, prolonged systemic retention and improved biopharmaceutical attributes. International Journal of Pharmaceutics 600, pages 120482.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.